Publications

Found 1 results
Filters: Author is X.M. Pu  [Clear All Filters]
2016
H. Yang, Lu, Q. L., Wu, X. J., Ma, H. Y., Qu, Y. Y., Zhang, D. Z., and Pu, X. M., Association of genetic variations in miR-146a rs2910164 and miR-149 rs11614913 with the development of classic Kaposi sarcoma, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSWe would like to acknowledge the Natural Science Foundation of China (#81260311) and the People’s Hospital of Xinjiang Uygur Autonomous Region (#20150115) for their support. REFERENCESChen XJ, Zhou TY, Chen M, Li N, et al (2015a). Association of the miRNA146a rs2910164 C>G polymorphism with head and neck cancer risk: a meta-analysis. Asian Pac. J. Cancer Prev. 16: 3871-3874. http://dx.doi.org/10.7314/APJCP.2015.16.9.3871 Chen ZF, Ma LL, Xue HB, et al (2015b). Common polymorphisms of the microRNA genes (miR-146a and miR-196a-2) and gastric cancer risk: an updated meta-analysis. Genet. Mol. Res. 14: 8589-8601. http://dx.doi.org/10.4238/2015.July.31.7 Cui Y, She K, Tian D, Zhang P, et al (2016). miR-146a inhibits proliferation and enhances chemosensitivity in epithelial ovarian cancer via reduction of SOD2. Oncol. Res. 23: 275-282. http://dx.doi.org/10.3727/096504016X14562725373798 Deng S, Wang W, Li X, Zhang P, et al (2015). Common genetic polymorphisms in pre-microRNAs and risk of bladder cancer. World J. Surg. Oncol. 13: 297. http://dx.doi.org/10.1186/s12957-015-0683-6 Friedman-Birnbaum R, Bergman R, Bitterman-Deutsch O, Weltfriend S, et al (1993). Classic and iatrogenic Kaposi’s sarcoma. Histopathological patterns as related to clinical course. Am. J. Dermatopathol. 15: 523-527. http://dx.doi.org/10.1097/00000372-199312000-00001 Gazouli M, Zavos G, Papaconstantinou I, Lukas JC, et al (2004). The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi’s sarcoma in renal transplant recipients. Anticancer Res. 24 (2C): 1311-1314. Gessain A, Duprez R, et al (2005). Spindle cells and their role in Kaposi’s sarcoma. Int. J. Biochem. Cell Biol. 37: 2457-2465. http://dx.doi.org/10.1016/j.biocel.2005.01.018 Guttman-Yassky E, Bar-Chana M, Yukelson A, Linn S, et al (2003). Epidemiology of classic Kaposi’s sarcoma in the Israeli Jewish population between 1960 and 1998. Br. J. Cancer 89: 1657-1660. http://dx.doi.org/10.1038/sj.bjc.6601313 Hashemi M, Moradi N, Ziaee SA, Narouie B, et al (2016). Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population. J. Adv. Res. 7: 491-498. http://dx.doi.org/10.1016/j.jare.2016.03.008 Ji HH, Hong-LuoHuang GL, Yin HX, et al (2015). Association between microRNA-196a2 rs11614913, microRNA-146a rs2910164, and microRNA-423 rs6505162 polymorphisms and esophageal cancer risk: A meta-analysis. Meta Gene 3: 14-25. http://dx.doi.org/10.1016/j.mgene.2014.12.001 Laresche C, Fournier E, Dupond AS, Woronoff AS, et al (2014). Kaposi’s sarcoma: a population-based cancer registry descriptive study of 57 consecutive cases diagnosed between 1977 and 2009. Int. J. Dermatol. 53: e549-e554. http://dx.doi.org/10.1111/ijd.12453 Macfarlane LA, Murphy PR, et al (2010). MicroRNA: biogenesis, function and role in cancer. Curr. Genomics 11: 537-561. http://dx.doi.org/10.2174/138920210793175895 Ouyang X, Zeng Y, Fu B, Wang X, et al (2014). Genotypic analysis of Kaposi’s sarcoma-associated herpesvirus from patients with Kaposi’s sarcoma in Xinjiang, China. Viruses 6: 4800-4810. http://dx.doi.org/10.3390/v6124800 Qi P, Wang L, Zhou B, Yao WJ, et al (2015). Associations of miRNA polymorphisms and expression levels with breast cancer risk in the Chinese population. Genet. Mol. Res. 14: 6289-6296. http://dx.doi.org/10.4238/2015.June.11.2 Sasaki H, Yoshiike M, Nozawa S, Usuba W, et al (2016). Expression level of urinary microRNA-146a-5p is increased in patients with bladder cancer and decreased in those after transurethral resection. Clin. Genitourin. Cancer 14: e493-e499. http://dx.doi.org/10.1016/j.clgc.2016.04.002 Shi Z, Johnson JJ, Jiang R, Liu Y, et al (2015). Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma. Arch. Oral Biol. 60: 1416-1427. http://dx.doi.org/10.1016/j.archoralbio.2015.06.007 Stiller CA, Trama A, Brewster DH, Verne J, RARECARE Working Groupet al (2014). Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project. Cancer Epidemiol. 38: 670-678. http://dx.doi.org/10.1016/j.canep.2014.09.009 van der Kuyl AC, Polstra AM, Weverling GJ, Zorgdrager F, et al (2004). An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi’s sarcoma: a case-control study. AIDS 18: 1206-1208. http://dx.doi.org/10.1097/00002030-200405210-00016 Wu XJ, Pu XM, Zhao ZF, Zhao YN, et al (2015). The expression profiles of microRNAs in Kaposi’s sarcoma. Tumour Biol. 36: 437-446. http://dx.doi.org/10.1007/s13277-014-2626-1 Xia ZG, Yin HF, Long Y, Cheng L, et al. (2016). Genetic variant of miR-146a rs2910164 C>G and gastric cancer susceptibility. Oncotarget [Epub ahead of print]. Yin Z, Cui Z, Ren Y, Xia L, et al (2016). Association between polymorphisms in pre-miRNA genes and risk of lung cancer in a Chinese non-smoking female population. Lung Cancer 94: 15-21. http://dx.doi.org/10.1016/j.lungcan.2016.01.013 Zhang L, Gao J, Zhou D, Bao F, et al (2015). Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to gastric cancer: A meta-analysis. Turk. J. Gastroenterol. 26: 378-385. http://dx.doi.org/10.5152/tjg.2015.6603